Improving the quality of life for people with ALS: The challenge ahead
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In tandem with recent progress in basic and clinical research in amyotrophic lateral sclerosis (ALS), clinical care and management has improved substantially. Key processes and practices have been established and are specified in current ALS Practice Parameters; the international ALS databases identify the current status of care and management given by physicians. A number of prospective clinical management research studies are now well underway to establish the effective utility of enteral feeding, assistive ventilatory device, and exercise in patients with ALS. One of the main research objectives in the clinical management of ALS is to improve patients' quality of life. For patients with ALS, only comprehensive multidisciplinary care can effectively improve their overall quality of life from diagnosis to death. This paper will briefly review a number of factors that must be considered if we are to improve the quality of life for these patients, including comprehensive medical management, patient education, the importance of hope, the role of the health care professional, and the patients themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
A New Approach to the Measurement of Quality of Life: The Patient-Generated Index
Ruta, D. A., Garratt, A. M., Leng, M., Russell, I. T., & MacDonald, L. M. (1994) · Medical Care · doi:10.1097/00005650-199411000-00004 · Cited by 527
Resilience and Distress Among Amyotrophic Lateral Sclerosis Patients and Caregivers
Rabkin, J. G., Wagner, G. J., & Del Bene, M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200003000-00020 · Cited by 288
Survival in Amyotrophic Lateral Sclerosis: The Role of Psychological Factors
McDonald, E. R. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130027010 · Cited by 193
Cited by
Multidisciplinary ALS care improves quality of life in patients with ALS
Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J. H. J., & Van den Berg, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000180717.29273.12 · Cited by 343
Dysarthria in amyotrophic lateral sclerosis: A review
Tomik, B., & Guiloff, R. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802379004 · Cited by 201
“Dysarthria significantly reduces the quality of life of ALS patients (6,7).”
BackgroundA cross sectional study on determinants of quality of life in ALS
Chio, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033100 · Cited by 190
The Dynamics of Quality of Life in ALS Patients and Caregivers
Roach, A. R., Averill, A. J., Segerstrom, S. C., & Kasarskis, E. J. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9092-9 · Cited by 81
“5 to 10 months), and some authors suggest that comprehensive medical care is a critical component in preserving patients' QOL throughout the disease course [16, 55–57].”
BackgroundInfluentialLipocalin‐2 is increased in amyotrophic lateral sclerosis
Petrozziello, T., Mills, A. N., Farhan, S. M. K., Mueller, K. A., Granucci, E. J., Glajch, K. E., Chan, J., Chew, S., Berry, J. D., & Sadri‐Vakili, G. (2020) · Muscle & Nerve · doi:10.1002/mus.26911 · Cited by 17
Metadata
- Authors
- Mitsumoto, H., & Bene, M. D.
- Venue
- Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
- Publisher
- Informa UK Limited
- Published
- 2000-01
- Volume
- 1
- Issue
- 5
- Pages
- 329-336
- ISSN
- 1466-0822 (ISSN-L)
- OpenAlex
- W2016666445
- Cited by
- 84
- References
- 4
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.